COVID-19 Impact on Global Preventive Vaccines Market Insights, Forecast to 2026
Preventive Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Preventive Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Preventive Vaccines market is segmented into
The Preventive Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Preventive Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Preventive Vaccines Market Share Analysis
Preventive Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Preventive Vaccines business, the date to enter into the Preventive Vaccines market, Preventive Vaccines product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Preventive Vaccines market is segmented into
- Intramuscular Injection
- Nasal Spray
- Intradermal Shot
- Hospital
- Clinic
- Other
The Preventive Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Preventive Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Preventive Vaccines Market Share Analysis
Preventive Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Preventive Vaccines business, the date to enter into the Preventive Vaccines market, Preventive Vaccines product introduction, recent developments, etc.
The major vendors covered:
- Sanofi
- AstraZeneca
- CSL Ltd
- Abbott
- GlaxoSmithKline
- Serum Institute of India
1 STUDY COVERAGE
1.1 Preventive Vaccines Product Introduction
1.2 Market Segments
1.3 Key Preventive Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Preventive Vaccines Market Size Growth Rate by Type
1.4.2 Intramuscular Injection
1.4.3 Nasal Spray
1.4.4 Intradermal Shot
1.5 Market by Application
1.5.1 Global Preventive Vaccines Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Preventive Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the Preventive Vaccines Industry
1.6.1.1 Preventive Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Preventive Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Preventive Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Preventive Vaccines Market Size Estimates and Forecasts
2.1.1 Global Preventive Vaccines Revenue 2015-2026
2.1.2 Global Preventive Vaccines Sales 2015-2026
2.2 Preventive Vaccines Market Size by Region: 2020 Versus 2026
2.2.1 Global Preventive Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Preventive Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PREVENTIVE VACCINES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Preventive Vaccines Sales by Manufacturers
3.1.1 Preventive Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Preventive Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Preventive Vaccines Revenue by Manufacturers
3.2.1 Preventive Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Preventive Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Preventive Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Preventive Vaccines Revenue in 2019
3.2.5 Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Preventive Vaccines Price by Manufacturers
3.4 Preventive Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Preventive Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Preventive Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Preventive Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Preventive Vaccines Market Size by Type (2015-2020)
4.1.1 Global Preventive Vaccines Sales by Type (2015-2020)
4.1.2 Global Preventive Vaccines Revenue by Type (2015-2020)
4.1.3 Preventive Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Preventive Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Preventive Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Preventive Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Preventive Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Preventive Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Preventive Vaccines Market Size by Application (2015-2020)
5.1.1 Global Preventive Vaccines Sales by Application (2015-2020)
5.1.2 Global Preventive Vaccines Revenue by Application (2015-2020)
5.1.3 Preventive Vaccines Price by Application (2015-2020)
5.2 Preventive Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Preventive Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Preventive Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Preventive Vaccines Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Preventive Vaccines by Country
6.1.1 North America Preventive Vaccines Sales by Country
6.1.2 North America Preventive Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Preventive Vaccines Market Facts & Figures by Type
6.3 North America Preventive Vaccines Market Facts & Figures by Application
7 EUROPE
7.1 Europe Preventive Vaccines by Country
7.1.1 Europe Preventive Vaccines Sales by Country
7.1.2 Europe Preventive Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Preventive Vaccines Market Facts & Figures by Type
7.3 Europe Preventive Vaccines Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Preventive Vaccines by Region
8.1.1 Asia Pacific Preventive Vaccines Sales by Region
8.1.2 Asia Pacific Preventive Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Preventive Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Preventive Vaccines Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Preventive Vaccines by Country
9.1.1 Latin America Preventive Vaccines Sales by Country
9.1.2 Latin America Preventive Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Preventive Vaccines Market Facts & Figures by Type
9.3 Central & South America Preventive Vaccines Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Preventive Vaccines by Country
10.1.1 Middle East and Africa Preventive Vaccines Sales by Country
10.1.2 Middle East and Africa Preventive Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Preventive Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Preventive Vaccines Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Preventive Vaccines Products Offered
11.1.5 Sanofi Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description, Business Overview and Total Revenue
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Preventive Vaccines Products Offered
11.2.5 AstraZeneca Recent Development
11.3 CSL Ltd
11.3.1 CSL Ltd Corporation Information
11.3.2 CSL Ltd Description, Business Overview and Total Revenue
11.3.3 CSL Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Ltd Preventive Vaccines Products Offered
11.3.5 CSL Ltd Recent Development
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Description, Business Overview and Total Revenue
11.4.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbott Preventive Vaccines Products Offered
11.4.5 Abbott Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Preventive Vaccines Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Serum Institute of India
11.6.1 Serum Institute of India Corporation Information
11.6.2 Serum Institute of India Description, Business Overview and Total Revenue
11.6.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Serum Institute of India Preventive Vaccines Products Offered
11.6.5 Serum Institute of India Recent Development
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Preventive Vaccines Products Offered
11.1.5 Sanofi Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Preventive Vaccines Market Estimates and Projections by Region
12.1.1 Global Preventive Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Preventive Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Preventive Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Preventive Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Preventive Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Preventive Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Preventive Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Preventive Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Preventive Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Preventive Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Preventive Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Preventive Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Preventive Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Preventive Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Preventive Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Preventive Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Preventive Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Preventive Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Preventive Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Preventive Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Preventive Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Preventive Vaccines Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Preventive Vaccines Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Preventive Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Preventive Vaccines Product Introduction
1.2 Market Segments
1.3 Key Preventive Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Preventive Vaccines Market Size Growth Rate by Type
1.4.2 Intramuscular Injection
1.4.3 Nasal Spray
1.4.4 Intradermal Shot
1.5 Market by Application
1.5.1 Global Preventive Vaccines Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Preventive Vaccines Industry Impact
1.6.1 How the Covid-19 is Affecting the Preventive Vaccines Industry
1.6.1.1 Preventive Vaccines Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Preventive Vaccines Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Preventive Vaccines Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Preventive Vaccines Market Size Estimates and Forecasts
2.1.1 Global Preventive Vaccines Revenue 2015-2026
2.1.2 Global Preventive Vaccines Sales 2015-2026
2.2 Preventive Vaccines Market Size by Region: 2020 Versus 2026
2.2.1 Global Preventive Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Preventive Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL PREVENTIVE VACCINES COMPETITOR LANDSCAPE BY PLAYERS
3.1 Preventive Vaccines Sales by Manufacturers
3.1.1 Preventive Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Preventive Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Preventive Vaccines Revenue by Manufacturers
3.2.1 Preventive Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Preventive Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Preventive Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Preventive Vaccines Revenue in 2019
3.2.5 Global Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Preventive Vaccines Price by Manufacturers
3.4 Preventive Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Preventive Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Preventive Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Preventive Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Preventive Vaccines Market Size by Type (2015-2020)
4.1.1 Global Preventive Vaccines Sales by Type (2015-2020)
4.1.2 Global Preventive Vaccines Revenue by Type (2015-2020)
4.1.3 Preventive Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Preventive Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Preventive Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Preventive Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Preventive Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Preventive Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Preventive Vaccines Market Size by Application (2015-2020)
5.1.1 Global Preventive Vaccines Sales by Application (2015-2020)
5.1.2 Global Preventive Vaccines Revenue by Application (2015-2020)
5.1.3 Preventive Vaccines Price by Application (2015-2020)
5.2 Preventive Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Preventive Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Preventive Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Preventive Vaccines Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Preventive Vaccines by Country
6.1.1 North America Preventive Vaccines Sales by Country
6.1.2 North America Preventive Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Preventive Vaccines Market Facts & Figures by Type
6.3 North America Preventive Vaccines Market Facts & Figures by Application
7 EUROPE
7.1 Europe Preventive Vaccines by Country
7.1.1 Europe Preventive Vaccines Sales by Country
7.1.2 Europe Preventive Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Preventive Vaccines Market Facts & Figures by Type
7.3 Europe Preventive Vaccines Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Preventive Vaccines by Region
8.1.1 Asia Pacific Preventive Vaccines Sales by Region
8.1.2 Asia Pacific Preventive Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Preventive Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Preventive Vaccines Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Preventive Vaccines by Country
9.1.1 Latin America Preventive Vaccines Sales by Country
9.1.2 Latin America Preventive Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Preventive Vaccines Market Facts & Figures by Type
9.3 Central & South America Preventive Vaccines Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Preventive Vaccines by Country
10.1.1 Middle East and Africa Preventive Vaccines Sales by Country
10.1.2 Middle East and Africa Preventive Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Preventive Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Preventive Vaccines Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Preventive Vaccines Products Offered
11.1.5 Sanofi Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Corporation Information
11.2.2 AstraZeneca Description, Business Overview and Total Revenue
11.2.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.2.4 AstraZeneca Preventive Vaccines Products Offered
11.2.5 AstraZeneca Recent Development
11.3 CSL Ltd
11.3.1 CSL Ltd Corporation Information
11.3.2 CSL Ltd Description, Business Overview and Total Revenue
11.3.3 CSL Ltd Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Ltd Preventive Vaccines Products Offered
11.3.5 CSL Ltd Recent Development
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Description, Business Overview and Total Revenue
11.4.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abbott Preventive Vaccines Products Offered
11.4.5 Abbott Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Corporation Information
11.5.2 GlaxoSmithKline Description, Business Overview and Total Revenue
11.5.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline Preventive Vaccines Products Offered
11.5.5 GlaxoSmithKline Recent Development
11.6 Serum Institute of India
11.6.1 Serum Institute of India Corporation Information
11.6.2 Serum Institute of India Description, Business Overview and Total Revenue
11.6.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Serum Institute of India Preventive Vaccines Products Offered
11.6.5 Serum Institute of India Recent Development
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Description, Business Overview and Total Revenue
11.1.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Sanofi Preventive Vaccines Products Offered
11.1.5 Sanofi Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Preventive Vaccines Market Estimates and Projections by Region
12.1.1 Global Preventive Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Preventive Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Preventive Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Preventive Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Preventive Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Preventive Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Preventive Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Preventive Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Preventive Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Preventive Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Preventive Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Preventive Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Preventive Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Preventive Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Preventive Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Preventive Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Preventive Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Preventive Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Preventive Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Preventive Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Preventive Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Preventive Vaccines Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Preventive Vaccines Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Preventive Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Preventive Vaccines Market Segments
Table 2. Ranking of Global Top Preventive Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Preventive Vaccines Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Intramuscular Injection
Table 5. Major Manufacturers of Nasal Spray
Table 6. Major Manufacturers of Intradermal Shot
Table 7. COVID-19 Impact Global Market: (Four Preventive Vaccines Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Preventive Vaccines Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Preventive Vaccines Players to Combat Covid-19 Impact
Table 12. Global Preventive Vaccines Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 13. Global Preventive Vaccines Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 14. Global Preventive Vaccines Sales by Regions 2015-2020 (K Doses)
Table 15. Global Preventive Vaccines Sales Market Share by Regions (2015-2020)
Table 16. Global Preventive Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Preventive Vaccines Sales by Manufacturers (2015-2020) (K Doses)
Table 18. Global Preventive Vaccines Sales Share by Manufacturers (2015-2020)
Table 19. Global Preventive Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Preventive Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventive Vaccines as of 2019)
Table 21. Preventive Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Preventive Vaccines Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Preventive Vaccines Price (2015-2020) (USD/Doses)
Table 24. Preventive Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Preventive Vaccines Product Type
Table 26. Date of International Manufacturers Enter into Preventive Vaccines Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 29. Global Preventive Vaccines Sales Share by Type (2015-2020)
Table 30. Global Preventive Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Preventive Vaccines Revenue Share by Type (2015-2020)
Table 32. Preventive Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Doses)
Table 33. Global Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 34. Global Preventive Vaccines Sales Share by Application (2015-2020)
Table 35. North America Preventive Vaccines Sales by Country (2015-2020) (K Doses)
Table 36. North America Preventive Vaccines Sales Market Share by Country (2015-2020)
Table 37. North America Preventive Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Preventive Vaccines Revenue Market Share by Country (2015-2020)
Table 39. North America Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 40. North America Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 41. North America Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 42. North America Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 43. Europe Preventive Vaccines Sales by Country (2015-2020) (K Doses)
Table 44. Europe Preventive Vaccines Sales Market Share by Country (2015-2020)
Table 45. Europe Preventive Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Preventive Vaccines Revenue Market Share by Country (2015-2020)
Table 47. Europe Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 48. Europe Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 49. Europe Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 50. Europe Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Preventive Vaccines Sales by Region (2015-2020) (K Doses)
Table 52. Asia Pacific Preventive Vaccines Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Preventive Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Preventive Vaccines Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 56. Asia Pacific Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 58. Asia Pacific Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 59. Latin America Preventive Vaccines Sales by Country (2015-2020) (K Doses)
Table 60. Latin America Preventive Vaccines Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Preventive Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Preventive Vaccines Revenue Market Share by Country (2015-2020)
Table 63. Latin America Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 64. Latin America Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 65. Latin America Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 66. Latin America Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Preventive Vaccines Sales by Country (2015-2020) (K Doses)
Table 68. Middle East and Africa Preventive Vaccines Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Preventive Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Preventive Vaccines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 72. Middle East and Africa Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 74. Middle East and Africa Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Major Businesses
Table 77. Sanofi Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 78. Sanofi Product
Table 79. Sanofi Recent Development
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Major Businesses
Table 82. AstraZeneca Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 83. AstraZeneca Product
Table 84. AstraZeneca Recent Development
Table 85. CSL Ltd Corporation Information
Table 86. CSL Ltd Description and Major Businesses
Table 87. CSL Ltd Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 88. CSL Ltd Product
Table 89. CSL Ltd Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Major Businesses
Table 92. Abbott Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 93. Abbott Product
Table 94. Abbott Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Major Businesses
Table 97. GlaxoSmithKline Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Serum Institute of India Corporation Information
Table 101. Serum Institute of India Description and Major Businesses
Table 102. Serum Institute of India Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 103. Serum Institute of India Product
Table 104. Serum Institute of India Recent Development
Table 105. Global Preventive Vaccines Sales Forecast by Regions (2021-2026) (K Doses)
Table 106. Global Preventive Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 107. Global Preventive Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 108. Global Preventive Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 109. North America: Preventive Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 110. North America: Preventive Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Europe: Preventive Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 112. Europe: Preventive Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Asia Pacific: Preventive Vaccines Sales Forecast by Region (2021-2026) (K Doses)
Table 114. Asia Pacific: Preventive Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 115. Latin America: Preventive Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 116. Latin America: Preventive Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Middle East and Africa: Preventive Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 118. Middle East and Africa: Preventive Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Preventive Vaccines Players
Table 123. Preventive Vaccines Customers List
Table 124. Preventive Vaccines Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
Table 1. Preventive Vaccines Market Segments
Table 2. Ranking of Global Top Preventive Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Preventive Vaccines Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Intramuscular Injection
Table 5. Major Manufacturers of Nasal Spray
Table 6. Major Manufacturers of Intradermal Shot
Table 7. COVID-19 Impact Global Market: (Four Preventive Vaccines Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Preventive Vaccines Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Preventive Vaccines Players to Combat Covid-19 Impact
Table 12. Global Preventive Vaccines Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 13. Global Preventive Vaccines Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 14. Global Preventive Vaccines Sales by Regions 2015-2020 (K Doses)
Table 15. Global Preventive Vaccines Sales Market Share by Regions (2015-2020)
Table 16. Global Preventive Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 17. Global Preventive Vaccines Sales by Manufacturers (2015-2020) (K Doses)
Table 18. Global Preventive Vaccines Sales Share by Manufacturers (2015-2020)
Table 19. Global Preventive Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 20. Global Preventive Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preventive Vaccines as of 2019)
Table 21. Preventive Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 22. Preventive Vaccines Revenue Share by Manufacturers (2015-2020)
Table 23. Key Manufacturers Preventive Vaccines Price (2015-2020) (USD/Doses)
Table 24. Preventive Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Preventive Vaccines Product Type
Table 26. Date of International Manufacturers Enter into Preventive Vaccines Market
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Global Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 29. Global Preventive Vaccines Sales Share by Type (2015-2020)
Table 30. Global Preventive Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 31. Global Preventive Vaccines Revenue Share by Type (2015-2020)
Table 32. Preventive Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Doses)
Table 33. Global Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 34. Global Preventive Vaccines Sales Share by Application (2015-2020)
Table 35. North America Preventive Vaccines Sales by Country (2015-2020) (K Doses)
Table 36. North America Preventive Vaccines Sales Market Share by Country (2015-2020)
Table 37. North America Preventive Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 38. North America Preventive Vaccines Revenue Market Share by Country (2015-2020)
Table 39. North America Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 40. North America Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 41. North America Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 42. North America Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 43. Europe Preventive Vaccines Sales by Country (2015-2020) (K Doses)
Table 44. Europe Preventive Vaccines Sales Market Share by Country (2015-2020)
Table 45. Europe Preventive Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 46. Europe Preventive Vaccines Revenue Market Share by Country (2015-2020)
Table 47. Europe Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 48. Europe Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 49. Europe Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 50. Europe Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 51. Asia Pacific Preventive Vaccines Sales by Region (2015-2020) (K Doses)
Table 52. Asia Pacific Preventive Vaccines Sales Market Share by Region (2015-2020)
Table 53. Asia Pacific Preventive Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 54. Asia Pacific Preventive Vaccines Revenue Market Share by Region (2015-2020)
Table 55. Asia Pacific Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 56. Asia Pacific Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 57. Asia Pacific Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 58. Asia Pacific Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 59. Latin America Preventive Vaccines Sales by Country (2015-2020) (K Doses)
Table 60. Latin America Preventive Vaccines Sales Market Share by Country (2015-2020)
Table 61. Latin Americaa Preventive Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 62. Latin America Preventive Vaccines Revenue Market Share by Country (2015-2020)
Table 63. Latin America Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 64. Latin America Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 65. Latin America Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 66. Latin America Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 67. Middle East and Africa Preventive Vaccines Sales by Country (2015-2020) (K Doses)
Table 68. Middle East and Africa Preventive Vaccines Sales Market Share by Country (2015-2020)
Table 69. Middle East and Africa Preventive Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 70. Middle East and Africa Preventive Vaccines Revenue Market Share by Country (2015-2020)
Table 71. Middle East and Africa Preventive Vaccines Sales by Type (2015-2020) (K Doses)
Table 72. Middle East and Africa Preventive Vaccines Sales Market Share by Type (2015-2020)
Table 73. Middle East and Africa Preventive Vaccines Sales by Application (2015-2020) (K Doses)
Table 74. Middle East and Africa Preventive Vaccines Sales Market Share by Application (2015-2020)
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Major Businesses
Table 77. Sanofi Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 78. Sanofi Product
Table 79. Sanofi Recent Development
Table 80. AstraZeneca Corporation Information
Table 81. AstraZeneca Description and Major Businesses
Table 82. AstraZeneca Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 83. AstraZeneca Product
Table 84. AstraZeneca Recent Development
Table 85. CSL Ltd Corporation Information
Table 86. CSL Ltd Description and Major Businesses
Table 87. CSL Ltd Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 88. CSL Ltd Product
Table 89. CSL Ltd Recent Development
Table 90. Abbott Corporation Information
Table 91. Abbott Description and Major Businesses
Table 92. Abbott Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 93. Abbott Product
Table 94. Abbott Recent Development
Table 95. GlaxoSmithKline Corporation Information
Table 96. GlaxoSmithKline Description and Major Businesses
Table 97. GlaxoSmithKline Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline Product
Table 99. GlaxoSmithKline Recent Development
Table 100. Serum Institute of India Corporation Information
Table 101. Serum Institute of India Description and Major Businesses
Table 102. Serum Institute of India Preventive Vaccines Production (K Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2015-2020)
Table 103. Serum Institute of India Product
Table 104. Serum Institute of India Recent Development
Table 105. Global Preventive Vaccines Sales Forecast by Regions (2021-2026) (K Doses)
Table 106. Global Preventive Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 107. Global Preventive Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 108. Global Preventive Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 109. North America: Preventive Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 110. North America: Preventive Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 111. Europe: Preventive Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 112. Europe: Preventive Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Asia Pacific: Preventive Vaccines Sales Forecast by Region (2021-2026) (K Doses)
Table 114. Asia Pacific: Preventive Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 115. Latin America: Preventive Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 116. Latin America: Preventive Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 117. Middle East and Africa: Preventive Vaccines Sales Forecast by Country (2021-2026) (K Doses)
Table 118. Middle East and Africa: Preventive Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 120. Key Challenges
Table 121. Market Risks
Table 122. Main Points Interviewed from Key Preventive Vaccines Players
Table 123. Preventive Vaccines Customers List
Table 124. Preventive Vaccines Distributors List
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Preventive Vaccines Product Picture
Figure 2. Global Preventive Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Intramuscular Injection Product Picture
Figure 4. Nasal Spray Product Picture
Figure 5. Intradermal Shot Product Picture
Figure 6. Global Preventive Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Preventive Vaccines Report Years Considered
Figure 11. Global Preventive Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Preventive Vaccines Sales 2015-2026 (K Doses)
Figure 13. Global Preventive Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Preventive Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Preventive Vaccines Sales Market Share by Region in 2019
Figure 16. Global Preventive Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Preventive Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Preventive Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Preventive Vaccines Revenue in 2019
Figure 20. Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Preventive Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Preventive Vaccines Sales Market Share by Type in 2019
Figure 23. Global Preventive Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Preventive Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Preventive Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Preventive Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Preventive Vaccines Sales Market Share by Application in 2019
Figure 28. Global Preventive Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Preventive Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Preventive Vaccines Sales Market Share by Country in 2019
Figure 33. North America Preventive Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Preventive Vaccines Market Share by Type in 2019
Figure 39. North America Preventive Vaccines Market Share by Application in 2019
Figure 40. Europe Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Preventive Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Preventive Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Preventive Vaccines Market Share by Type in 2019
Figure 55. Europe Preventive Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Preventive Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Preventive Vaccines Revenue Market Share by Region in 2019
Figure 60. China Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Preventive Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Preventive Vaccines Market Share by Application in 2019
Figure 84. Latin America Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Preventive Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Preventive Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Preventive Vaccines Market Share by Type in 2019
Figure 95. Latin America Preventive Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Preventive Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Preventive Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Preventive Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Preventive Vaccines Market Share by Application in 2019
Figure 108. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. CSL Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. North America Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 117. Europe Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 119. Asia Pacific Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 121. Latin America Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 123. Middle East and Africa Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
Figure 1. Preventive Vaccines Product Picture
Figure 2. Global Preventive Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. Intramuscular Injection Product Picture
Figure 4. Nasal Spray Product Picture
Figure 5. Intradermal Shot Product Picture
Figure 6. Global Preventive Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Preventive Vaccines Report Years Considered
Figure 11. Global Preventive Vaccines Market Size 2015-2026 (US$ Million)
Figure 12. Global Preventive Vaccines Sales 2015-2026 (K Doses)
Figure 13. Global Preventive Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Preventive Vaccines Sales Market Share by Region (2015-2020)
Figure 15. Global Preventive Vaccines Sales Market Share by Region in 2019
Figure 16. Global Preventive Vaccines Revenue Market Share by Region (2015-2020)
Figure 17. Global Preventive Vaccines Revenue Market Share by Region in 2019
Figure 18. Global Preventive Vaccines Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Preventive Vaccines Revenue in 2019
Figure 20. Preventive Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Preventive Vaccines Sales Market Share by Type (2015-2020)
Figure 22. Global Preventive Vaccines Sales Market Share by Type in 2019
Figure 23. Global Preventive Vaccines Revenue Market Share by Type (2015-2020)
Figure 24. Global Preventive Vaccines Revenue Market Share by Type in 2019
Figure 25. Global Preventive Vaccines Market Share by Price Range (2015-2020)
Figure 26. Global Preventive Vaccines Sales Market Share by Application (2015-2020)
Figure 27. Global Preventive Vaccines Sales Market Share by Application in 2019
Figure 28. Global Preventive Vaccines Revenue Market Share by Application (2015-2020)
Figure 29. Global Preventive Vaccines Revenue Market Share by Application in 2019
Figure 30. North America Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 31. North America Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Preventive Vaccines Sales Market Share by Country in 2019
Figure 33. North America Preventive Vaccines Revenue Market Share by Country in 2019
Figure 34. U.S. Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 35. U.S. Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 37. Canada Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Preventive Vaccines Market Share by Type in 2019
Figure 39. North America Preventive Vaccines Market Share by Application in 2019
Figure 40. Europe Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 41. Europe Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Preventive Vaccines Sales Market Share by Country in 2019
Figure 43. Europe Preventive Vaccines Revenue Market Share by Country in 2019
Figure 44. Germany Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 45. Germany Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 47. France Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 49. U.K. Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 51. Italy Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 53. Russia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Preventive Vaccines Market Share by Type in 2019
Figure 55. Europe Preventive Vaccines Market Share by Application in 2019
Figure 56. Asia Pacific Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 57. Asia Pacific Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Preventive Vaccines Sales Market Share by Region in 2019
Figure 59. Asia Pacific Preventive Vaccines Revenue Market Share by Region in 2019
Figure 60. China Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 61. China Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 63. Japan Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 65. South Korea Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 67. India Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 69. Australia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 71. Taiwan Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 73. Indonesia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 75. Thailand Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 77. Malaysia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 79. Philippines Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 81. Vietnam Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Preventive Vaccines Market Share by Type in 2019
Figure 83. Asia Pacific Preventive Vaccines Market Share by Application in 2019
Figure 84. Latin America Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 85. Latin America Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Preventive Vaccines Sales Market Share by Country in 2019
Figure 87. Latin America Preventive Vaccines Revenue Market Share by Country in 2019
Figure 88. Mexico Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 89. Mexico Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 91. Brazil Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 93. Argentina Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Preventive Vaccines Market Share by Type in 2019
Figure 95. Latin America Preventive Vaccines Market Share by Application in 2019
Figure 96. Middle East and Africa Preventive Vaccines Sales Growth Rate 2015-2020 (K Doses)
Figure 97. Middle East and Africa Preventive Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Preventive Vaccines Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Preventive Vaccines Revenue Market Share by Country in 2019
Figure 100. Turkey Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 101. Turkey Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 103. Saudi Arabia Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Preventive Vaccines Sales Growth Rate (2015-2020) (K Doses)
Figure 105. U.A.E Preventive Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Preventive Vaccines Market Share by Type in 2019
Figure 107. Middle East and Africa Preventive Vaccines Market Share by Application in 2019
Figure 108. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. CSL Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Serum Institute of India Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. North America Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 115. North America Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Europe Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 117. Europe Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Asia Pacific Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 119. Asia Pacific Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Latin America Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 121. Latin America Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Middle East and Africa Preventive Vaccines Sales Growth Rate Forecast (2021-2026) (K Doses)
Figure 123. Middle East and Africa Preventive Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Porter's Five Forces Analysis
Figure 125. Channels of Distribution
Figure 126. Distributors Profiles
Figure 127. Bottom-up and Top-down Approaches for This Report
Figure 128. Data Triangulation
Figure 129. Key Executives Interviewed
